SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-108169
Filing Date
2020-04-15
Accepted
2020-04-15 16:49:04
Documents
8
Period of Report
2020-05-28
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d857534ddef14a.htm DEF 14A 666586
2 GRAPHIC g857534dsp001.jpg GRAPHIC 115783
3 GRAPHIC g857534dsp002.jpg GRAPHIC 121848
4 GRAPHIC g857534g00y43.jpg GRAPHIC 18799
5 GRAPHIC g857534g33v20.jpg GRAPHIC 73903
6 GRAPHIC g857534g46k52.jpg GRAPHIC 80959
7 GRAPHIC g857534g48y82.jpg GRAPHIC 77809
8 GRAPHIC g857534g78f41.jpg GRAPHIC 75682
  Complete submission text file 0001193125-20-108169.txt   1446753
Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 9419231949
NEOGENOMICS INC (Filer) CIK: 0001077183 (see all company filings)

IRS No.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35756 | Film No.: 20794213
SIC: 8734 Services-Testing Laboratories